A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma
Condition(s):Appendiceal Adenocarcinoma; ColorectalLast Updated:December 6, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Appendiceal Adenocarcinoma; ColorectalLast Updated:December 6, 2023Active, not recruiting
Condition(s):Metastatic Appendiceal Adenocarcinoma; Intraperitoneal PaclitaxelLast Updated:February 1, 2024Recruiting
Condition(s):Colorectal CancerLast Updated:June 24, 2020Unknown status
Condition(s):Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the RectumLast Updated:October 20, 2022Terminated
Condition(s):Noninvasive Mucinous Cystadenocarcinoma of OvaryLast Updated:December 31, 2014Unknown status
Condition(s):Gastrointestinal NeoplasmsLast Updated:October 13, 2023Active, not recruiting
Condition(s):Appendiceal CancerLast Updated:July 11, 2022Completed
Condition(s):CancerLast Updated:October 31, 2019Terminated
Condition(s):Colorectal Adenocarcinoma; Mucinous Adenocarcinoma; Signet Ring Cell AdenocarcinomaLast Updated:January 30, 2024Recruiting
Condition(s):Ovarian Clear Cell Cystadenocarcinoma; Stage III Ovarian Cancer; Stage IV Ovarian CancerLast Updated:August 8, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.